PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS

Pseudo-Lennox syndrome (PLS), or atypical benign partial epilepsy of childhood, is a disease from a group of age-related epileptic encephalopathies with a phenomenon of continuous spike-wave activity during slow sleep, which manifests itself as frequent polymorphic focal motor and pseudogeneralized...

Full description

Bibliographic Details
Main Author: K. Yu. Mukhin
Format: Article
Language:Russian
Published: ABV-press 2016-04-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/134
_version_ 1826558021322407936
author K. Yu. Mukhin
author_facet K. Yu. Mukhin
author_sort K. Yu. Mukhin
collection DOAJ
description Pseudo-Lennox syndrome (PLS), or atypical benign partial epilepsy of childhood, is a disease from a group of age-related epileptic encephalopathies with a phenomenon of continuous spike-wave activity during slow sleep, which manifests itself as frequent polymorphic focal motor and pseudogeneralized seizures, cognitive impairments, as well as regional and diffuse epileptiform activity on electroencephalogram (EEG) by the morphology identical to that of benign epileptiform patterns of childhood. The disease was first described by J. Aicardi and J. J. Chevrie in 1982, based on a study of 7 cases. Its diagnostic complexity is the polymorphism of both epileptic seizures and EEG data, as well as low awareness of the syndrome among physicians and its absence in the international classification of epilepsies. The typical triad of seizures, which occurs in nearly 100 % of patients, encompasses focal motor paroxysms (identical to those as observed in Rolandic epilepsy), atypical absences, and atonic seizures. Seizures in PLS in its active period (generally up to 7–8 years) are highly resistant to antiepileptic drugs. Only a few agents have been proven to be effective in PLS; these include valproates, succinimides, benzodiazepines, topiramate, and sulthiame. The frequency of seizures are noted to increase in patients with PLS treated with drugs, such as vigabatrin, gabapentin, lamotrigine, phenobarbital, or phenytoin. The author considers in detail the history of studies of the disease, clinical manifestations, diagnostic criteria, therapeutic approaches, and prognosis.
first_indexed 2024-04-10T01:32:27Z
format Article
id doaj.art-47a0987a69944747a9d9a61bff995032
institution Directory Open Access Journal
issn 2073-8803
2412-9178
language Russian
last_indexed 2025-03-14T08:37:52Z
publishDate 2016-04-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj.art-47a0987a69944747a9d9a61bff9950322025-03-02T12:58:00ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782016-04-0111171310.17650/2073-8803-2016-11-1-7-13110PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICSK. Yu. Mukhin0Svt. Luka’s Institute of Child Neurology and EpilepsyPseudo-Lennox syndrome (PLS), or atypical benign partial epilepsy of childhood, is a disease from a group of age-related epileptic encephalopathies with a phenomenon of continuous spike-wave activity during slow sleep, which manifests itself as frequent polymorphic focal motor and pseudogeneralized seizures, cognitive impairments, as well as regional and diffuse epileptiform activity on electroencephalogram (EEG) by the morphology identical to that of benign epileptiform patterns of childhood. The disease was first described by J. Aicardi and J. J. Chevrie in 1982, based on a study of 7 cases. Its diagnostic complexity is the polymorphism of both epileptic seizures and EEG data, as well as low awareness of the syndrome among physicians and its absence in the international classification of epilepsies. The typical triad of seizures, which occurs in nearly 100 % of patients, encompasses focal motor paroxysms (identical to those as observed in Rolandic epilepsy), atypical absences, and atonic seizures. Seizures in PLS in its active period (generally up to 7–8 years) are highly resistant to antiepileptic drugs. Only a few agents have been proven to be effective in PLS; these include valproates, succinimides, benzodiazepines, topiramate, and sulthiame. The frequency of seizures are noted to increase in patients with PLS treated with drugs, such as vigabatrin, gabapentin, lamotrigine, phenobarbital, or phenytoin. The author considers in detail the history of studies of the disease, clinical manifestations, diagnostic criteria, therapeutic approaches, and prognosis.https://rjdn.abvpress.ru/jour/article/view/134epilepsyepileptic encephalopathypseudo-lennox syndromeelectroencephalographybenign epileptiform discharges of childhoodclinical presentationdiagnosistreatmentprognosis
spellingShingle K. Yu. Mukhin
PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS
Русский журнал детской неврологии
epilepsy
epileptic encephalopathy
pseudo-lennox syndrome
electroencephalography
benign epileptiform discharges of childhood
clinical presentation
diagnosis
treatment
prognosis
title PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS
title_full PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS
title_fullStr PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS
title_full_unstemmed PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS
title_short PSEUDO-LENNOX SYNDROME: CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS
title_sort pseudo lennox syndrome clinical and electroencephalographic characteristics
topic epilepsy
epileptic encephalopathy
pseudo-lennox syndrome
electroencephalography
benign epileptiform discharges of childhood
clinical presentation
diagnosis
treatment
prognosis
url https://rjdn.abvpress.ru/jour/article/view/134
work_keys_str_mv AT kyumukhin pseudolennoxsyndromeclinicalandelectroencephalographiccharacteristics